Nonstructural protein 5A/P32 deletion after failure of ledipasvir/sofosbuvir in hepatitis C virus genotype 1b infection

被引：17
|
作者：
Doi, Akira [1 ]
Hikita, Hayato [1 ]
Sakamori, Ryotaro [1 ]
Tahata, Yuki [1 ]
Kai, Yugo [1 ]
Yamada, Ryoko [1 ]
Yakushijin, Takayuki [2 ]
Mita, Eiji [3 ]
Ohkawa, Kazuyoshi [4 ]
Imai, Yasuharu [5 ]
Furuta, Kunimaro [1 ]
Kodama, Takahiro [1 ]
Tatsumi, Tomohide [1 ]
Takehara, Tetsuo [1 ]
机构：
[1] Osaka Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan
[2] Osaka Gen Med Ctr, Dept Gastroenterol & Hepatol, Osaka, Japan
[3] Osaka Natl Hosp, Natl Hosp Org, Dept Gastroenterol & Hepatol, Osaka, Japan
[4] Osaka Int Canc Inst, Dept Hepatobiliary & Pancreat Oncol, Osaka, Japan
[5] Ikeda Municipal Hosp, Ikeda, Osaka, Japan
来源：
HEPATOLOGY | 2018年 / 68卷 / 01期
关键词：
D O I：
10.1002/hep.29836
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：380 / 383
页数：4
相关论文
共 50 条
  • [21] Efficacy and safety of ledipasvir/sofosbuvir for genotype 1b chronic hepatitis C patients with moderate renal impairment
    Okubo, Tomomi
    Atsukawa, Masanori
    Tsubota, Akihito
    Toyoda, Hidenori
    Shimada, Noritomo
    Abe, Hiroshi
    Kato, Keizo
    Hayama, Korenobu
    Arai, Taeang
    Nakagawa-Iwashita, Ai
    Itokawa, Norio
    Kondo, Chisa
    Kawamoto, Chiaki
    Iio, Etsuko
    Tanaka, Yasuhito
    Kumada, Takashi
    Iwakiri, Katsuhiko
    HEPATOLOGY INTERNATIONAL, 2018, 12 (02) : 133 - 142
  • [22] Interferon sensitivity-determining region of nonstructural region 5A of hepatitis C virus genotype 1b correlates with serum alanine aminotransferase levels in chronic infection
    Yoshioka, K
    Ito, H
    Watanabe, K
    Yano, M
    Ishigami, M
    Mizutani, T
    Sasaki, Y
    Goto, H
    JOURNAL OF VIRAL HEPATITIS, 2005, 12 (02) : 139 - 145
  • [23] Case report: successful retreatment of hepatitis C genotype 1b infection with sofosbuvir
    Safadi, Rifaat
    Noviello, Stephanie
    Boparai, Navdeep
    McPhee, Fiona
    CLINICAL CASE REPORTS, 2016, 4 (07): : 653 - 656
  • [24] Grazoprevir/elbasvir treatment for the relapse of HCV genotype 1b infection after ledipasvir/sofosbuvir: A case report
    Tadokoro, Tomoko
    Morishita, Asahiro
    Oura, Kyoko
    Fujita, Koji
    Mimura, Shima
    Sakamoto, Teppei
    Nomura, Takako
    Tani, Joji
    Yoneyama, Hirohito
    Masaki, Tsutomu
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 16 (02) : 1026 - 1028
  • [25] Evaluation of IFN-free Therapy Using Ledipasvir/sofosbuvir in Patients with Hepatitis C Virus genotype-1b Infection
    Kaya, Daisuke
    Nakatani, Toshiya
    Tomooka, Masafumi
    Fujimoto, Yuki
    Ishida, Koji
    Fujinaga, Yukihisa
    Takagi, Hirotetsu
    Saikawa, Soichiro
    Aihara, Yosuke
    Nagamatsu, Shinsaku
    Shimozato, Naotaka
    Matsuo, Hideki
    Kikuchi, Eiryo
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S1273 - S1273
  • [26] Mutations in the nonstructural protein 5A gene and virological response to interferon in Turkish patients chronically infected with hepatitis C virus type 1b
    Akkiz, H
    Colakoglu, S
    Ergun, Y
    Sandikci, M
    Serin, M
    Oksuz, M
    Isiksal, F
    Kacak, F
    Abayli, B
    JOURNAL OF HEPATOLOGY, 2001, 34 : 141 - 141
  • [27] Ledipasvir and sofosbuvir in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis: An integrated safety and efficacy analysis
    Reddy, K. Rajender
    Bourliere, Marc
    Sulkowski, Mark
    Omata, Masao
    Zeuzem, Stefan
    Feld, Jordan J.
    Lawitz, Eric
    Marcellin, Patrick
    Welzel, Tania M.
    Hyland, Robert
    Ding, Xiao
    Yang, Jenny
    Knox, Steven
    Pang, Phillip
    Dvory-Sobol, Hadas
    Subramanian, G. Mani
    Symonds, William
    McHutchison, John G.
    Mangia, Alessandra
    Gane, Edward
    Mizokami, Masashi
    Pol, Stanislas
    Afdhal, Nezam
    HEPATOLOGY, 2015, 62 (01) : 79 - 86
  • [28] Combination of Ledipasvir and Sofosbuvir for Treatment of Hepatitis C Virus Genotype 1 Infection: Systematic Review and Meta-Analysis
    Rezaee-Zavareh, Mohammad Saeid
    Hesamizadeh, Khashayar
    Behnava, Bita
    Alavian, Seyed Moayed
    Gholami-Fesharaki, Mohammad
    Sharafi, Heidar
    ANNALS OF HEPATOLOGY, 2017, 16 (02) : 188 - 197
  • [29] Real-World Retreatment of Sofosbuvir/Ledipasvir (SOF/LDV) Failures In Hepatitis C Virus Genotype 1 infection
    Pearlman, Brian
    Hinds, Andrew
    Perrys, Michael
    HEPATOLOGY, 2016, 64 : 478A - 478A
  • [30] Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b-infected null responders
    Chayama, Kazuaki
    Takahashi, Shoichi
    Toyota, Joji
    Karino, Yoshiyasu
    Ikeda, Kenji
    Ishikawa, Hiroki
    Watanabe, Hideaki
    McPhee, Fiona
    Hughes, Eric
    Kumada, Hiromitsu
    HEPATOLOGY, 2012, 55 (03) : 742 - 748
12345